Robert Smith, MD
Vascular Surgery · Temple, TXNPI 1023335007
Payments from drug & device makers
Across 88 payments — averaging $283.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bolton Medical Inc$18K
- W. L. Gore & Associates, Inc.$4K
- Medtronic$1K
- Silk Road Medical, Inc.$682
- Edwards Lifesciences$355
- Phathom Pharmaceuticals, Inc.$102
- plus $167 from 5 others
What the payments were for
- Travel & lodging$1,81025%
- Food & beverage$5,29675%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bolton Medical Inc | 9 | $17,847 |
| W. L. Gore & Associates, Inc. | 51 | $4,294 |
| Medtronic(2 entities) | 15 | $1,477 |
| Silk Road Medical, Inc. | 5 | $682 |
| Edwards Lifesciences | 2 | $355 |
| Phathom Pharmaceuticals, Inc. | 1 | $102 |
| Lemaitre Vascular, Inc. | 1 | $75 |
| Solventum Corporation | 1 | $28 |
| Neuros Medical, Inc. | 1 | $25 |
| Inari Medical, Inc. | 1 | $25 |
| Terumo Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Conformable Thoracic Stent Graft$672
- ENROUTE Transcarotid Stent$650
- ENROUTE Transcarotid Neuroprotection System$650
- GORE TAG Thoracic Endoprosthesis$532
- ENDURANT IIS$481
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$477
- GORE TAG Thoracic Branch Endoprosthesis$386
- GORE VIABAHN VBX Balloon Expandable Endo$364
- COREVALVE EVOLUT R$297
- Endurant$263
- GORE VIABAHN Endoprosthesis with Heparin$207
- SAPIEN 3 Ultra RESILIA$200
- APOLLOTM$162
- GORE EXCLUDER AAA Endoprosthesis$139
- VIABAHN VBX Balloon Expandable Endoprosthesis$133
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$123
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$107
- ENROUTE .014 Guidewire$107
- ENHANCE Transcarotid Peripheral Access Kit$107
- C3 Delivery System$103
How this compares
$24,924 in reported general payments places this provider in the 75th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Temple
- William BohannonTemple$82K
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- Samuel LeonardHouston$431K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.